Category: Press Release

Explore all our news . .

Recent Posts

LPSN FRIDAY DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages LivePerson, Inc. Investors to Secure Counsel Before Important June 23 Deadline in First Filed Securities Class Action Commenced by the Firm – LPSN

NEW YORK, June 21, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of LivePerson, Inc. (NASDAQ: LPSN) between May 10, 2022 and March 16, 2023, both dates inclusive (the “Class Period”), of the important June 23, 2023 lead plaintiff

ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – CRL

NEW YORK, June 21, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Charles River Laboratories International, Inc. (NYSE: CRL) between May 5, 2020 and February 21, 2023, both dates inclusive (the “Class Period”), of the important July 18,

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages DZS Inc. Investors with Losses to Secure Counsel Before Important Deadline in First Filed Securities Class Action Commenced by the Firm – DZSI

NEW YORK, June 21, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of DZS Inc. (NASDAQ: DZSI) between March 10, 2023 and May 31, 2023, both dates inclusive (the “Class Period”), of the important August 14, 2023 lead plaintiff

James Absalom Elevated to Chief Commercial Officer – International at ZRG

LONDON and NEW YORK, June 21, 2023 (GLOBE NEWSWIRE) — ZRG Partners, a leading global talent firm backed by private equity firm RFE Investment Partners, today announced the promotion of London-based executive James Absalom to the position of Chief Commercial Officer – International. Absalom became part of ZRG when his

Curia Expands Cell Line Development Offering with CHOZN Platform

Curia signs license agreement with MilliporeSigma to support production of proteins and antibodies ALBANY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced it has signed a licensing agreement with MilliporeSigma, the North American Life Sciences Business of Merck KGaA, Darmstadt,